Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "neuro-rehabilitation"

3 News Found

KIMS Hospitals launches Institute of Advanced Neurosciences in Bengaluru
Hospitals | May 04, 2026

KIMS Hospitals launches Institute of Advanced Neurosciences in Bengaluru

New Centre of Excellence at Electronic City campus to offer specialised care in epilepsy, cerebrovascular disorders, neurointervention, skull base and spine surgery

KIMS Hospitals launches Advanced Neurosciences Institute in Bengaluru
Healthcare | May 04, 2026

KIMS Hospitals launches Advanced Neurosciences Institute in Bengaluru

The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof

Experts seek insurance coverage for stroke rehabilitation as recovery costs rise
Healthcare | April 10, 2026

Experts seek insurance coverage for stroke rehabilitation as recovery costs rise

Experts also underscored the growing role of technologies such as tele-neurorehabilitation, robotics, and AI-driven therapies in improving recovery outcomes

Latest Stories

Lupin launches Atharv ability neuro-rehabilitation centre in Delhi

Alembic Pharma Q4 revenue rises to Rs. 1,848 crore

Amrutanjan Healthcare expands portfolio in pain management

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Precision oncology must be decentralized to reach every patient: Dr Vidya Veldore, Vice President, Clinical Operations, 4baseCare
Precision oncology must be decentralized to reach every patient: Dr Vidya Veldore, Vice President, Clinical Operations, 4baseCare
Dr Vidya Veldore Vice President, Clinical Operations, 4baseCare
AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX
AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX
Dushyant Sapre Founder and CEO, SwishX
Agentic AI poised to reshape pharma operations beyond pilot-stage adoption: Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital
Agentic AI poised to reshape pharma operations beyond pilot-stage adoption: Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital
Duraisamy Rajan Palani Founder and CEO, Archimedis Digital

Packaging